Goldman Sachs opened its 46th Annual Global Healthcare Conference today in Miami, bringing together pharmaceutical executives, biotech leaders and investors as the industry grapples with rising costs and the integration of artificial intelligence into patient care.
The three-day conference, running through June 11, features presentations from major healthcare companies including Regeneron Pharmaceuticals, Merck, and several emerging biotech firms. The gathering comes as healthcare costs have surged 119% since 2000, outpacing general inflation by more than 30 percentage points.
Regeneron kicked off today's sessions with Chief Financial Officer Christopher Fenimore and investor relations head Ryan Crowe discussing the company's EYLEA franchise and late-stage pipeline strategy1. The biotech giant's presentation at 10:40 a.m. was among the first of dozens scheduled throughout the conference.
Other notable participants include Quanterix, whose CEO Masoud Toloue presented on ultrasensitive biomarker detection technology this afternoon2, and Alvotech, which announced that Chief Strategy Officer Dr. Balaji Prasad will participate in a fireside chat Wednesday morning focused on biosimilar medicines3.
TG Therapeutics Chairman Michael Weiss is scheduled to present Tuesday on the company's B-cell disease treatments, including its recently approved multiple sclerosis drug BRIUMVI4.
The conference unfolds against a backdrop of mounting challenges for healthcare providers and pharmaceutical companies. Rising pharmaceutical costs, medical supply expenses, and labor shortages are creating financial strain across the industry1.
Healthcare organizations are increasingly turning to artificial intelligence and machine learning to address operational inefficiencies, with nurse practitioners leading efforts to leverage AI for patient data analysis and remote monitoring2. The American Association of Nurse Practitioners identified AI technologies as one of five critical healthcare trends for 2025.
The shift toward value-based care models and increased pricing transparency represents another focus area as the industry seeks to balance quality care delivery with cost containment1.
Goldman Sachs moved the conference to Miami in 2024 after years of hosting it in California locations including Rancho Palos Verdes and Dana Point1. The firm has tentatively scheduled Miami as the venue through 2032, according to industry event listings.
"Patients nationwide deserve access to high-quality health care, and NPs are experts in various fields, including primary care, elder care, mental health care, substance use disorder treatment and artificial intelligence innovations," said AANP President Stephen A. Ferrara2.
